Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women

NCT00330096 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Osteopenia

Interventions

DRUG: Hesperidin
OTHER: Placebo

Sponsor

Société des Produits Nestlé (SPN)

Collaborators

[object Object]
[object Object]